Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
4.170
-0.200 (-4.58%)
Jan 13, 2025, 4:00 PM EST - Market closed
Evoke Pharma Employees
Evoke Pharma had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$2,154,259
Profits / Employee
-$1,536,707
Market Cap
8.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
EVOK News
- 25 days ago - Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends - GlobeNewsWire
- 5 weeks ago - Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI® - GlobeNewsWire
- 2 months ago - InvestCloud to Partner with Evoke Advisors to Transform Their Digital Experience - Business Wire
- 2 months ago - Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Evoke Pharma stock surges over 100%—here's why - Invezz
- 2 months ago - Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting - GlobeNewsWire
- 2 months ago - Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors - GlobeNewsWire
- 3 months ago - Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion - GlobeNewsWire